Starting Jan. 1, older adults on Medicare will have a $2,000 cap on out-of-pocket spending on prescription drugs, offering major relief to those struggling with high costs, such as cancer patients like Diana DiVito, who spent $56,000 on Imbruvica. The new cap, part of the Inflation Reduction Act, applies to Medicare Part D drugs, benefiting millions of enrollees and easing financial burdens on patients like the Scotts, who faced skyrocketing costs due to serious health issues in 2023.
Full Article